RU2005113661A - Композиция, содержащая натриевую соль правастатина - Google Patents

Композиция, содержащая натриевую соль правастатина Download PDF

Info

Publication number
RU2005113661A
RU2005113661A RU2005113661/04A RU2005113661A RU2005113661A RU 2005113661 A RU2005113661 A RU 2005113661A RU 2005113661/04 A RU2005113661/04 A RU 2005113661/04A RU 2005113661 A RU2005113661 A RU 2005113661A RU 2005113661 A RU2005113661 A RU 2005113661A
Authority
RU
Russia
Prior art keywords
composition containing
containing sodium
pravastatin salt
sodium pravastatin
sodium salt
Prior art date
Application number
RU2005113661/04A
Other languages
English (en)
Inventor
Нобунари СУГИО (JP)
Нобунари СУГИО
Ясуюки ТАКАМАЦУ (JP)
Ясуюки ТАКАМАЦУ
Сунси КОДЗИМА (JP)
Сунси КОДЗИМА
Муцуо СУЗУКИ (JP)
Муцуо СУЗУКИ
Минору ХАГИСАВА (JP)
Минору ХАГИСАВА
Кийоси ХАМАНО (JP)
Кийоси ХАМАНО
Original Assignee
Санкио Компани, Лимитед (Jp)
Санкио Компани, Лимитед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=18794392&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=RU2005113661(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Санкио Компани, Лимитед (Jp), Санкио Компани, Лимитед filed Critical Санкио Компани, Лимитед (Jp)
Publication of RU2005113661A publication Critical patent/RU2005113661A/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00—Preparation of carboxylic acid esters
    • C07C67/48—Separation; Purification; Stabilisation; Use of additives
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02—Oxygen as only ring hetero atoms
    • C12P17/06—Oxygen as only ring hetero atoms containing a six-membered hetero ring, e.g. fluorescein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00—Preparation of carboxylic acid esters
    • C07C67/48—Separation; Purification; Stabilisation; Use of additives
    • C07C67/58—Separation; Purification; Stabilisation; Use of additives by liquid-liquid treatment
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00—Preparation of carboxylic acid esters
    • C07C67/48—Separation; Purification; Stabilisation; Use of additives
    • C07C67/60—Separation; Purification; Stabilisation; Use of additives by treatment giving rise to chemical modification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/02—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen
    • C07C69/22—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen having three or more carbon atoms in the acid moiety
    • C07C69/33—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen having three or more carbon atoms in the acid moiety esterified with hydroxy compounds having more than three hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/62—Carboxylic acid esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/14—All rings being cycloaliphatic
    • C07C2602/26—All rings being cycloaliphatic the ring system containing ten carbon atoms
    • C07C2602/28—Hydrogenated naphthalenes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Claims (2)

1. Композиция, содержащая натриевую соль правастатина, которая производится промышленностью и содержит соединение формулы (I), количество которого составляет 0,1 мас.% или менее по отношению к количеству натриевой соли правастатина
Figure 00000001
2. Композиция, содержащая натриевую соль правастатина по п.30, которая производится промышленностью и содержит 99,5% или выше натриевой соли правастатина.
RU2005113661/04A 2000-10-16 2005-05-04 Композиция, содержащая натриевую соль правастатина RU2005113661A (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000-315256 2000-10-16
JP2000315256A JP3236282B1 (ja) 2000-10-16 2000-10-16 プラバスタチンを精製する方法

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
RU2003110580/04A Division RU2260582C2 (ru) 2000-10-16 2001-10-15 Способ очистки правастатина

Publications (1)

Publication Number Publication Date
RU2005113661A true RU2005113661A (ru) 2006-11-10

Family

ID=18794392

Family Applications (2)

Application Number Title Priority Date Filing Date
RU2003110580/04A RU2260582C2 (ru) 2000-10-16 2001-10-15 Способ очистки правастатина
RU2005113661/04A RU2005113661A (ru) 2000-10-16 2005-05-04 Композиция, содержащая натриевую соль правастатина

Family Applications Before (1)

Application Number Title Priority Date Filing Date
RU2003110580/04A RU2260582C2 (ru) 2000-10-16 2001-10-15 Способ очистки правастатина

Country Status (19)

Country Link
US (1) US20030216596A1 (ru)
EP (4) EP1327626A4 (ru)
JP (1) JP3236282B1 (ru)
KR (1) KR20030042018A (ru)
CN (4) CN1481353A (ru)
AU (1) AU2001294258A1 (ru)
BR (1) BR0114681A (ru)
CA (1) CA2425883A1 (ru)
CZ (1) CZ20031052A3 (ru)
HU (1) HUP0303106A3 (ru)
IL (1) IL155360A0 (ru)
MX (1) MXPA03003347A (ru)
NO (1) NO20031739L (ru)
NZ (3) NZ536892A (ru)
PL (1) PL360934A1 (ru)
RU (2) RU2260582C2 (ru)
SK (1) SK4532003A3 (ru)
WO (1) WO2002032848A1 (ru)
ZA (1) ZA200302966B (ru)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW589178B (en) * 2003-02-21 2004-06-01 China Chemical & Pharmaceutica A novel industrial process to obtain pravastatin sodium of high purity
EP1452519A1 (en) * 2003-02-25 2004-09-01 Balkanpharma-Razgrad AD Method for the isolation and purification of pravastatin sodium
US7642287B2 (en) * 2004-08-06 2010-01-05 Transform Pharmaceuticals, Inc. Statin pharmaceutical compositions and related methods of treatment
US20090042979A1 (en) * 2004-08-06 2009-02-12 Transform Pharmaceuticals Inc. Novel Statin Pharmaceutical Compositions and Related Methods of Treatment
BRPI0513082A (pt) * 2004-08-06 2008-04-22 Transform Pharmaceuticals Inc formulações de fenofibrato e métodos de tratamento relacionados
CN100361954C (zh) * 2005-05-16 2008-01-16 天津市冠东科技有限公司 制备普伐他汀结晶体的干燥方法
JP4813841B2 (ja) * 2005-07-25 2011-11-09 キユーピー株式会社 プラバスタチンナトリウムの製造方法
US8734795B2 (en) * 2008-10-31 2014-05-27 Biogen Idec Ma Inc. Light targeting molecules and uses thereof
CN109796333B (zh) * 2019-01-25 2021-04-09 北大方正集团有限公司 一种从发酵液中提取纯化普伐他汀钠的方法
CN112778120B (zh) * 2019-11-08 2024-05-17 上海现代制药股份有限公司 一种降血脂类药物氧化杂质的制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK149080C (da) * 1980-06-06 1986-07-28 Sankyo Co Fremgangsmaade til fremstilling af derivater af ml-236b-carboxylsyre
JPS5889191A (ja) * 1981-11-20 1983-05-27 Sankyo Co Ltd ３−ヒドロキシ−ｍｌ−２３６ｂ誘導体の製造法
US5202029A (en) * 1991-03-13 1993-04-13 Caron Kabushiki Kaisha Process for purification of hmg-coa reductase inhibitors
NZ250609A (en) * 1992-12-28 1995-07-26 Sankyo Co Hexahydronaphthalene esters and ring closed lactones; preparation and medicaments
ES2145479T3 (es) * 1995-08-03 2000-07-01 Dsm Nv Procedimiento mejorado de obtencion de lovastatina, compactina o pravastatina.
SI20305A (sl) * 1999-08-06 2001-02-28 LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. Kristali natrijeve soli pravastatina
HUP9902352A1 (hu) * 1999-07-12 2000-09-28 Gyógyszerkutató Intézet Kft. Eljárás pravasztatin mikrobiológiai előállítására
PL361230A1 (en) * 2000-10-05 2004-10-04 Biogal Gyogyszergyar Rt. Pravastatin sodium substantially free of pravastatin lactone and epi-pravastatin, and compositions containing same

Also Published As

Publication number Publication date
BR0114681A (pt) 2003-12-09
HUP0303106A2 (hu) 2003-12-29
CZ20031052A3 (cs) 2003-09-17
MXPA03003347A (es) 2003-06-19
PL360934A1 (en) 2004-09-20
KR20030042018A (ko) 2003-05-27
SK4532003A3 (en) 2003-10-07
WO2002032848A1 (fr) 2002-04-25
NO20031739D0 (no) 2003-04-15
EP1327626A4 (en) 2004-08-18
CN1868996A (zh) 2006-11-29
HUP0303106A3 (en) 2004-10-28
AU2001294258A1 (en) 2002-04-29
US20030216596A1 (en) 2003-11-20
RU2260582C2 (ru) 2005-09-20
EP1514862A1 (en) 2005-03-16
CN1690037A (zh) 2005-11-02
NO20031739L (no) 2003-06-13
NZ536891A (en) 2005-05-27
CA2425883A1 (en) 2003-04-15
EP1514863A1 (en) 2005-03-16
JP2002121174A (ja) 2002-04-23
EP1522589A1 (en) 2005-04-13
IL155360A0 (en) 2003-11-23
NZ525256A (en) 2005-01-28
NZ536892A (en) 2005-05-27
CN1679535A (zh) 2005-10-12
CN1481353A (zh) 2004-03-10
JP3236282B1 (ja) 2001-12-10
EP1327626A1 (en) 2003-07-16
ZA200302966B (en) 2004-07-15

Similar Documents

Publication Publication Date Title
RU2005113661A (ru) Композиция, содержащая натриевую соль правастатина
RU2695274C3 (ru) Новые композиции и способы их стабилизации
EA200100139A1 (ru) Фармацевтические композиции, содержащие 2-хинолоны
EP2039699A3 (en) Extractive methods for purifying sucralose
EA200300705A1 (ru) Смеси соединения модафинила и циклодекстрина
DK1166762T3 (da) Sammensætninger indeholdende mineralvand
MY141869A (en) Mouth rinse compositions
DE50209545D1 (de) Flüssigkristallines medium
DK1399530T3 (da) Biocide rengöringssammensætninger
DE69111607D1 (de) Reine kristalline form von rifapentin.
EP2168956A3 (en) Synthesis of 2-Hydroxy-N,N-Dimethyl-3-[[2-[1(r) - (5-Methyl-2-Furanyl) Propyl] -3, 4-Dioxo-1-Cyclobuten-1-Yl]amino] Benzamide
ES557620A0 (es) Procedimiento para la obtencion de s.s.-dioxido dce 3-acetilamino-4-metoxibenzoisotiazol.
RU2002124524A (ru) Производные n-деацетилтиоколхицина и содержащие их фармацевтические композиции
TR200400293T4 (tr) 9-dihidro-13-asetilbasatin III'e ait suda çözünebilir 9-dihidro-paklitaksel türevlerinin sentezi.
TW200502235A (en) Novel benzo[1,2,5]thiadiazoles and pharmaceutical use thereof
RU2000125255A (ru) 2',3'-дидегидро-2',3'-дидезокситимидин-5'[(этоксикарбонил)(этил)фосфонат]- ингибитор репродукции вируса иммунодефицита человека
RU2224742C2 (ru) Промежуточные соединения для синтеза производных бензимидазола и способ их получения
RU2003106393A (ru) Твердый препарат с высоким всасыванием
RU2003107054A (ru) Новые соединения триоксепана
ES2163487T3 (es) Conjugados de hirudina a partir de hirudina y compuestos lipofilos.
DE60219462D1 (de) Verdickte wässrige zusammensetzungen
RU2002132890A (ru) Способ и композиции для ингибирования артериосклероза
EP1312608A3 (en) Discodermolide analogues and their pharmaceutical use
RU97100301A (ru) Жидкие составы глифозата
AR018935A1 (es) Compuesto derivado de la tienopiridina, proceso para producirlo, composicion farmaceutica que lo contiene, y su uso para elaborar dicha composicion

Legal Events

Date Code Title Description
FA93 Acknowledgement of application withdrawn (no request for examination)

Effective date: 20080527